SGLT2i use linked to reduced risk for flare in adults with gout, T2D
For patients with gout and type 2 diabetes, sodium-glucose cotransporter-2 inhibitors (SGLT2is) are associated with a reduced risk for recurrent gout flares and gout-primary emergency department visits and hospitalizations, ...
Jul 25, 2023
0
0